Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering WALTHAM, Mass. --  Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating [...]

CAMBRIDGE, Mass. — Elemental Machines, a pioneer in life sciences operational intelligence, today announced the next evolution of its operations with the expanded launch of its Agentic AI Platform. This release transforms how laboratories and manufacturing facilities turn equipment, facility, and environmental data into strategic decisions to improve operational efficiency. The first two Elemental Machines’ [...]

TAIPEI -- Illumina Taiwan Biotechnology Co., Ltd., and Precision Medicine Asia, Limited (PREMIA), a leading Asian cancer clinical-genomic screening network, today announced the formation of a strategic partnership that will expand access to comprehensive genomic profiling (CGP) for all eligible oncology patients across the Chang Gung Memorial Hospital (CGMH) system. This partnership also aims to support the [...]

Collaboration makes AI models trained on over $1 billion in Lilly research data accessible directly in scientists' workflows SAN FRANCISCO -- Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform created by Eli Lilly and Company (Lilly) to provide access to models trained on decades [...]

Veeva’s expanded manufacturing QC solutions to automate environmental sample collection and analysis PLEASANTON, CA — Veeva Systems (NYSE: VEEV) today announced a new environmental monitoring (EM) solution to advance quality control (QC) for manufacturing operations. Veeva Environmental Monitoring, a cloud-native application unified with Veeva LIMS, will enable laboratories and manufacturing facilities to schedule, collect, and analyze environmental samples [...]

Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster, from strategy to measurable outcomes. AUSTIN, TX and MINNEAPOLIS, MN – L7 Informatics, Inc., and Turnberry Solutions, Inc. today announced the completion of a strategic Teaming Agreement, establishing a formal collaboration to jointly pursue enterprise digital transformation initiatives [...]

CAMBRIDGE, Mass. -- Elemental Machines, a pioneer in life sciences operational intelligence, today announced the next evolution of its operations with the expanded launch of its Agentic AI Platform. This release transforms how laboratories and manufacturing facilities turn equipment, facility, and environmental data into strategic decisions to improve operational efficiency. The first two Elemental Machines’ [...]

Abbelight Announces Successful Series B Investment led by AVANT BIO to accelerate imaging innovation and scale adoption across a broader customer base. Paris, France – January 8, 2026 – Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth [...]

Community-developed approach combines multi-contact 3C with HiFi sequencing to deliver haplotype-resolved assemblies from minimal input material MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced CiFi, a new community-developed method that enables chromosome-scale, haplotype-resolved genome assemblies from a single sequencing run, even when sample material is limited. [...]

Early Access Program participants receive exclusive use of Nautilus’ Iterative Mapping method, initially through a validated tau proteoforms assay, with the potential to accelerate Alzheimer’s and neurodegenerative disease research SEATTLE -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced the launch of an Early Access Program for its [...]